Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 21 Show results per page	View Search Criteria \| Help With Results


1.		A Phase I/II Study of the Photon Radiosurgery System

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				2 to 32				Other				CNS 0201 NCT00179907


2.		Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				1 to 120				Other				R01 CA 89395-01 Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959


3.		A Multi-Center Phase I Study of AP23573 in Pediatric Patients With Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				1 to 17				Other				SUN08-01 NCT00704054

Last Modified: 11/2/2007 First Published: 11/1/1998


4.		Phase II Study of Antineoplastons A10 and AS2-1 in Children With Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				6 months to 17 years				Other				BC-BT-10 NCT00003458

Last Modified: 12/7/2007 First Published: 11/1/1998


5.		Phase II Study of Antineoplastons A10 and AS2-1 in Children With Primary Malignant Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				6 months to 17 years				Other				BC-BT-22 NCT00003476


6.		Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and under				Other				UMCC 9626 IRB 1996-195, NCT00141765

Last Modified: 8/16/2008 First Published: 3/2/2007


7.		Phase II Study of Intrathecal Iodine I 131 Monoclonal Antibody 3F8 in Patients With GD2-Expressing Central Nervous System or Leptomeningeal Neoplasms

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				Other				MSKCC-05122 NCT00445965


8.		Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-Cis-Retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				6 months to 21 years				Other				NYU 05-40 H12853 PBMTC ONC-032P, NCT00528437


9.		Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				Other				3368 NCT00576537

Last Modified: 9/8/2008


10.		Phase I Study of Photodynamic Therapy With Benzoporphyrin Derivative Monoacid Ring A in Patients With Refractory Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				3 to 70				Other				MCW-7594 MCW-CHW-511, MCW-CHW-9411, NCI-V95-0652, NCT00002647

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute